Violaine H.
- Country
- Belgium
- Department
- Hematology
Research Overview
- Phase 3 Randomized Double‑Blind Study of Pelabresib (DAK539) Plus Ruxolitinib vs Placebo + Ruxolitinib in JAK‑Inhibitor‑Naive Adults with Myelofibrosis
- First-in-Human, Open-Label Study of INCA035784 in Adults with Myeloproliferative Neoplasms
- Evaluation of Revumenib Combined with Azacitidine and Venetoclax in Newly Diagnosed NPM1-Mutated or KMT2A-Rearranged AML Patients Ineligible for Intensive Chemotherapy
Data & Insights
Has run more than one trial at 64 of 252 partner sites.
Specializations
Hematologic Malignancies
This investigator specializes in treating various forms of blood cancers, with particular emphasis on acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Their expertise includes managing these conditions in specific patient populations, including adults ineligible for intensive treatments and younger adults aged 18-59 years.
- IDH1 mutation-positive AML
- Adult Acute Lymphoblastic Leukemia
Their focus includes investigating novel therapeutic combinations for improved patient outcomes.
Myeloproliferative Disorders
The investigator has significant involvement in treating myeloproliferative neoplasms (MPN) and their complications. Their work encompasses the management of myelofibrosis and associated conditions, particularly focusing on addressing anemia in affected patients.
- MPN-associated Myelofibrosis
- Transfusion-dependent Anemia
Their research interests include exploring novel therapeutic approaches for patients receiving JAK2 inhibitor therapy.
Innovative Therapeutics
The investigator explores cutting-edge treatments in hematology, including targeted therapies and novel drug combinations. Their work involves evaluating new therapeutic agents for various blood disorders.
- Combination Therapy Approaches
- JAK Inhibitor-based Treatments
- Novel Therapeutic Agents
Their research encompasses the evaluation of emerging treatments for previously untreated patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.